Form 10-Q CATALYST PHARMACEUTICALS For: Mar 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Catyalyst Pharma (CPRX) Reports In-Line Q1 Loss
May 10, 2016 4:57 PM EDTCatyalyst Pharma (NASDAQ: CPRX) reported Q1 EPS of ($0.07), in-line with the analyst estimate of ($0.07).
Upcoming 2016 Milestones
Collaboratively working with the FDA to finalize a regulatory path forward for FirdapseInitiate the confirmatory Phase 3 trial for... More